Efficacy and safety of niraparib combined with oral etoposide in platinum-resistant/refractory ovarian cancer (PROC): a single arm, phase 2 study

Proceedings of the 7th Biennial Meeting of Asian Society of Gynecologic Oncology(2021)

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要